APA (7th ed.) Citation

Tomooka, F., Moriya, K., Kubo, T., Shibamoto, A., Suzuki, J., Iwai, S., . . . Mitoro, A. (2023). Plasma copeptin concentration is a predictor of tolvaptan efficacy in patients with hepatic ascites. Portal Hypertension & Cirrhosis, 2(3), 109. https://doi.org/10.1002/poh2.55

Chicago Style (17th ed.) Citation

Tomooka, Fumimasa, et al. "Plasma Copeptin Concentration Is a Predictor of Tolvaptan Efficacy in Patients with Hepatic Ascites." Portal Hypertension & Cirrhosis 2, no. 3 (2023): 109. https://doi.org/10.1002/poh2.55.

MLA (9th ed.) Citation

Tomooka, Fumimasa, et al. "Plasma Copeptin Concentration Is a Predictor of Tolvaptan Efficacy in Patients with Hepatic Ascites." Portal Hypertension & Cirrhosis, vol. 2, no. 3, 2023, p. 109, https://doi.org/10.1002/poh2.55.